Postoperative complications in the seriously mentally ill: A systematic review of the literature

Annals of Surgery

Volumn 248, Issue 1, 2008, Pages 31-38

  Copeland, Laurel A ^a,b   Zeber, John E ^a,b   Pugh, Mary Jo ^a,c   Mortensen, Eric M ^a,c   Restrepo, Marcos I ^a,c   Lawrence, Valerie A ^a,c  

^a SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BUPIVACAINE; BUPRENORPHINE; DICLOFENAC; FENTANYL; HALOPERIDOL; KETAMINE; NEUROLEPTIC AGENT; NITROUS OXIDE; PENTAZOCINE; PROPOFOL; SEVOFLURANE;

ANALGESIA; ARTICLE; BIPOLAR DISORDER; CASE STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONFUSION; CONTINUOUS INFUSION; DELIRIUM; EPIDURAL ANESTHESIA; HUMAN; MAJOR DEPRESSION; MEDLINE; MENTAL DISEASE; PAIN; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHIZOPHRENIA; SINGLE DRUG DOSE; SURGICAL RISK; SYSTEMATIC REVIEW; COMORBIDITY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; HUMANS; INTRAOPERATIVE COMPLICATIONS; MENTAL DISORDERS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SCHIZOPHRENIA;

EID: 48949118940     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181724f25     Document Type: Article

References (42)

1. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry. 1993;163:183-189.
2. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry. 2000;177:212-217.
3. Curkendall SM, Mo J, Glasser DB, et al. Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. J Clin Psychiatry. 2004;65:715-720.
4. Kudoh A. Perioperative management for chronic schizophrenic patients. Anesth Analg. 2005;101:1867-1872.
5. Copeland LA, Zeber JE, Mortensen EM, et al. Surgery rates among Veterans with Schizophrenia. International congress on Schizophrenia research. Colorado Springs, CO, 2007.
6. Daumit GL, Pronovost PJ, Anthony CB, et al. Adverse events during medical and surgical hospitalizations for persons with schizophrenia. Arch Gen Psychiatry. 2006;63:267-272.
7. Cooke BK, Magas LT, Virgo KS, et al. Appendectomy for appendicitis in patients with schizophrenia. Am J Surg. 2007;193:41-48.
8. Goldman LS. Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999;60(suppl 21):S10-S15.
9. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: randomised controlled trial. BMJ. 1996;312:345-349.
10. Matsuki A, Oyama T, Izai S, et al. Excessive mortality in schizophrenic patients on chronic phenothiazines treatment. Agressologie. 1972;13:407-418.
11. Ishihara H, Kudo H, Murakawa T, et al. Uneventful total intravenous anaesthesia with ketamine for schizophrenic surgical patients. Eur J Anaesthesiol. 1997;14:47-51.
12. Kudoh A, Ishihara H, Matsuki A. Current perception thresholds and postoperative pain in schizophrenic patients. Reg Anesth Pain Med. 2000;25:475-479.
13. Kudoh A, Katagai H, Takazawa T. Effect of epidural analgesia on postoperative paralytic ileus in chronic schizophrenia. Reg Anesth Pain Med. 2001;26:456-460.
14. Kudoh A, Takahira Y, Katagai H, et al. Schizophrenic patients who develop postoperative confusion have an increased norepinephrine and cortisol response to surgery. Neuropsychobiology. 2002;46:7-12.
15. Kudoh A, Katagai H, Takazawa T. Anesthesia with ketamine, propofol, and fentanyl decreases the frequency of postoperative psychosis emergence and confusion in schizophrenic patients. J Clin Anesth. 2002;14:107-110.
16. Kudoh A, Takase H, Takahira Y, et al. Postoperative confusion in schizophrenic patients is affected by interleukin-6. J lin Anesth. 2003;15:455-462.
17. Kudoh A, Katagai H, Takase H, et al. Effect of preoperative discontinuation of antipsychotics in schizophrenic patients on outcome during and after anaesthesia. Eur J Anaesthesiol. 2004;21:414-416.
18. Kudoh A, Takahira Y, Katagai H, et al. Cortisol response to surgery and postoperative confusion in depressed patients under general anesthesia with fentanyl. Neuropsychobiology. 2002;46:22-26.
19. Kudoh A, Katagai H, Takazawa T. Antidepressant treatment for chronic depressed patients should not be discontinued prior to anesthesia. Can J Anaesth. 2002;49:132-136.
20. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941-948.
21. Bar KJ, Boettger MK, Koschke M, et al. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol. 2007;118:2009-2015.
22. Tirupati S, Chua LE. Obesity and metabolic syndrome in a psychiatric rehabilitation service. Aust N Z J Psychiatry. 2007;41:606 -610.
23. Copeland LA, Mortensen EM, Zeber JE, et al. Pulmonary disease among inpatient decedents: Impact of schizophrenia. Prog Neuropsychophar- macol Biol Psychiatry. 2007;31:720 -726.
24. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. JNerv Ment Dis. 2004;192:421-427.
25. Pugh MJ, Fincke BG, Bierman AS, et al. Potentially inappropriate prescribing in elderly veterans: are we using the wrong drug, wrong dose, or wrong duration? J Am Geriatr Soc. 2005;53:1282-1289.
26. Osby U, Correia N, Brandt L, et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res. 2000;45:21-28.
27. Holt RI, Bushe C, Citrome L. Diabetes and schizophrenia 2005: are we any closer to understanding the link? J Psychopharmacol. 2005, 19 (6 suppl):S56 -S65.
28. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294:716 -724.
29. Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia. Med. J. Aust2003;178(suppl):S67-S70.
30. Rounsaville BJ. DSM-V research agenda: substance abuse/psychosis comorbidity. Schizophr Bull. 2007;33:947-952.
31. Arnow BA, Hunkeler EM, Blasey CM, et al. Comorbid depression, chronic pain, and disability in primary care. Psychosom Med. 2006;68:262-268.
32. Johnson KM, Bradley KA, Bush K, et al. Frequency of mastalgia among women veterans. Association with psychiatric conditions and unexplained pain syndromes. J Gen Intern Med. 2006;21(suppl 3):S70-S75.
33. Zeigler PP. Treatment of pain in the patient with a substance use disorder. Psychiatr Times. 2007;24:1.
34. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291:1753-1762.
35. Milbrandt EB, Kersten A, Kong L, et al. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 2005;33:226 -229, discussion 263-265.
36. Khuri SF. Safety, quality, and the National Surgical Quality Improvement Program. Am Surg. 2006;72:994-998; discussion 1021-1030, 1133-1148.
37. Fink AS, Campbell DA Jr, Mentzer RM Jr, et al. The National Surgical Quality Improvement Program in non-veterans administration hospitals: initial demonstration of feasibility. Ann Surg. 236:344-353, 2002; discussion 353-354.
38. Dixon L, Weiden P, Delahanty J, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26:903-912.
39. Tarone RE, Chu KC. Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA. J. Epidemiol Biostat. 2000;5:221-231.
40. Daumit GL, Pratt LA, Crum RM, et al. Characteristics of primary care visits for individuals with severe mental illness in a national sample. Gen Hosp Psychiatry. 2002;24:391-395.
41. Gfroerer JC, Penne MA, Pemberton MR. The aging Baby Boom Cohort and future prevalence of substance abuse. In: Korper SP, Council CL, eds. Substance Use by Older Adults: Estimates of Future Impact on the Treatment System. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies, 2002. Available at: http://www.oas.samhsa.gov/Aging/chap5.htm.
42. ADA. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabet Care. 2004;27:596 -601.